News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,726 Results
Type
Article (39753)
Company Profile (193)
Press Release (684765)
Multimedia
Podcasts (127)
Webinars (30)
Section
Business (228831)
Career Advice (1740)
Deals (34400)
Drug Delivery (144)
Drug Development (76753)
Employer Resources (161)
FDA (16370)
Job Trends (14618)
News (338038)
Policy (32668)
Tag
2027 BioCapital Standard (3)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (5)
2027 Genetown Elite (3)
2027 Genetown Standard (7)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (7)
40 Under 40 (1)
Academia (2279)
Accelerated approval (58)
ADA (45)
Adcomms (25)
Allergies (205)
Alliances (48901)
ALS (221)
Alzheimer's disease (1792)
Antibody-drug conjugate (ADC) (562)
Approvals (17042)
Artificial intelligence (865)
ASCO (283)
Autoimmune disease (406)
Automation (69)
Bankruptcy (344)
Belgium (14)
Best Places to Work (11261)
BIO (71)
Biologics (43)
BIOSECURE Act (19)
Biosimilars (226)
BioSpace Insights (164)
Biotechnology (123)
Bispecific (13)
Bladder cancer (215)
Brain cancer (83)
Breast cancer (827)
Cancer (6499)
Cardiovascular disease (520)
Career advice (1513)
Career pathing (49)
CAR-T (328)
CDC (58)
CDMO (141)
Celiac Disease (7)
Cell-line development (1)
Cell therapy (928)
Cervical cancer (60)
Clinical research (69028)
Collaboration (2323)
Commercialization (32)
Company closure (5)
Compensation (1697)
Complete response letters (91)
COVID-19 (2148)
CRISPR (114)
CRO (1)
C-suite (1481)
Cystic fibrosis (148)
Data (9321)
Decentralized trials (3)
Denatured (48)
Depression (184)
Dermatology (161)
Diabetes (697)
Diagnostics (6867)
Digital health (69)
Diversity (13)
Diversity, equity & inclusion (38)
Drug discovery (387)
Drug pricing (212)
Drug shortages (36)
Duchenne muscular dystrophy (303)
Earnings (89002)
Editorial (77)
Employer branding (19)
Employer resources (142)
Events (120693)
Executive appointments (1241)
Eye disease (7)
FDA (20955)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (33)
Funding (1902)
Gene editing (227)
Generative AI (72)
Gene therapy (708)
GLP-1 (1015)
Government (4501)
Grass and pollen (4)
Guidances (414)
Healthcare (18394)
Hematology (167)
HIV (97)
Huntington's disease (60)
Idiopathic pulmonary fibrosis (11)
IgA nephropathy (121)
Immunology and inflammation (257)
Immuno-oncology (114)
Indications (254)
Infectious disease (2503)
Inflammatory bowel disease (235)
Inflation Reduction Act (16)
Influenza (134)
Intellectual property (342)
Interviews (286)
IPO (15825)
IRA (54)
Job creations (3674)
Job search strategy (1262)
JPM (55)
Kidney cancer (25)
Kidney disease (110)
Labor market (115)
Layoffs (403)
Leadership (50)
Legal (8139)
Licensing (50)
Liver cancer (100)
Longevity (43)
Lung cancer (934)
Lung diease (16)
Lymphoma (480)
Machine learning (69)
Management (57)
Manufacturing (1257)
Marketing (18)
MASH (218)
Medical affairs (3)
Medical device (14805)
Medtech (15091)
Mergers & acquisitions (20061)
Metabolic disorders (1642)
mRNA (212)
Multiple sclerosis (215)
Multispecific (2)
NASH (16)
Netherlands (13)
Neurodegenerative disease (440)
Neuropsychiatric disorders (109)
Neuroscience (3502)
Neurotech (1)
NextGen: Class of 2026 (6311)
Non-profit (3931)
Now hiring (67)
Obesity (700)
Opinion (329)
Ovarian cancer (262)
Pain (298)
Pancreatic cancer (362)
Parkinson's disease (400)
Partnered (39)
Patents (697)
Patient advocacy (1)
Patient recruitment (887)
Patient selection (48)
Peanut (66)
People (61430)
Peptides (19)
Pharmaceutical (47)
Pharmacy benefit managers (37)
Phase 1 (21417)
Phase 2 (30359)
Phase 3 (22441)
Pipeline (12044)
Policy (327)
Postmarket research (2493)
Preclinical (8854)
Press Release (68)
Prostate cancer (345)
Psychedelics (66)
Radioligand (1)
Radiopharmaceuticals (365)
Rare diseases (1194)
Real estate (5750)
Recruiting (69)
Regenerative medicine (15)
Regulatory (26464)
Reports (58)
Research institute (2230)
Resumes & cover letters (276)
Rett syndrome (53)
RNA editing (23)
RSV (83)
Schizophrenia (194)
Series A (331)
Series B (232)
Service/supplier (6)
Sickle cell disease (112)
Special edition (25)
Spinal muscular atrophy (166)
Sponsored (40)
Startups (3556)
State (2)
Stem cells (3)
Stomach cancer (17)
Substance use disorders (21)
Supply chain (140)
Switzerland (1)
Tariffs (90)
The Weekly (77)
Vaccines (942)
Venture capital (115)
Weight loss (439)
Wet AMD (2)
Women's health (163)
Worklife (21)
Date
Today (127)
Last 7 days (593)
Last 30 days (2412)
Last 365 days (29111)
2026 (22679)
2025 (28673)
2024 (33485)
2023 (38263)
2022 (49049)
2021 (53310)
2020 (51959)
2019 (44708)
2018 (33683)
2017 (30805)
2016 (30344)
2015 (36486)
2014 (30787)
2013 (26473)
2012 (28940)
2011 (29259)
2010 (27960)
Location
Africa (732)
Alabama (105)
Alaska (7)
Arizona (428)
Arkansas (17)
Asia (39651)
Australia (6094)
California (15242)
Canada (4166)
China (1635)
Colorado (680)
Connecticut (650)
Delaware (457)
Europe (80568)
Florida (2348)
Georgia (496)
Hawaii (4)
Idaho (63)
Illinois (1293)
India (106)
Indiana (637)
Iowa (27)
Japan (676)
Kansas (146)
Kentucky (53)
Louisiana (56)
Maine (46)
Maryland (1838)
Massachusetts (10727)
Michigan (414)
Minnesota (846)
Mississippi (7)
Missouri (148)
Montana (32)
Nebraska (28)
Nevada (157)
New Hampshire (84)
New Jersey (4026)
New Mexico (27)
New York (3955)
North Carolina (1959)
North Dakota (11)
Northern California (7755)
Ohio (485)
Oklahoma (27)
Oregon (41)
Pennsylvania (2885)
Puerto Rico (34)
Rhode Island (55)
South America (1056)
South Carolina (96)
South Dakota (1)
Southern California (6174)
Tennessee (254)
Texas (2553)
United States (53640)
Utah (478)
Vermont (2)
Virginia (349)
Washington D.C. (77)
Washington State (1221)
West Virginia (4)
Wisconsin (179)
Wyoming (5)
724,726 Results for "medical action industries inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WHS Recognizes Eluciderm, Inc. with Industrial R&D Award for Research on ELU42 Mechanism of Action
April 21, 2026
·
4 min read
Press Releases
QT Imaging Appoints Imaging Industry Veteran Dr. Mark Winkler as Chief Medical Officer
September 17, 2026
·
8 min read
Press Releases
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger
July 2, 2026
·
6 min read
Press Releases
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
August 25, 2026
·
2 min read
Press Releases
Nitto Avecia Achieves Third Consecutive FDA Inspection with No Action Indicated
October 7, 2026
·
2 min read
Press Releases
IGC Pharma Unveils PRISM AI Platform to Move Alzheimer’s Risk Prediction to Brain-Health Action and Commercial Deployment
October 13, 2026
·
9 min read
Press Releases
Northwest Biotherapeutics Announces MOU for Collaboration With the Saudi Pharmaceutical Industries and Medical Appliance Company
August 6, 2026
·
6 min read
Press Releases
Utah Medical Products, Inc. Extends Tender Offer - October 5, 2026
October 5, 2026
·
1 min read
Press Releases
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
July 13, 2026
·
4 min read
Press Releases
OS Therapies Appoints Industry Leader Dr. Craig Eagle as Chief Medical Advisor
• Appointment strengthens medical, regulatory, and commercial leadership as Company prepares to complete early market access regulatory filings in the U.S., U.K, Europe and Australia in anticipation of OST-HER2 approval decisions expected by year-end 2026 • Upcoming FDA Pre-BLA meeting will focus on the use of recent seroconversion biomarker data as a key surrogate clinical efficacy endpoint to support a BLA for OST-HER2 under the Accelerated Approval Program • Commercialization and reimbursement preparations well underway for the U.S., U.K., and Europe in parallel with ongoing partnership discussions
May 14, 2026
·
7 min read
1 of 72,473
Next
